Cannabis-based drug launched to treat epilepsy in children
Akumentis Healthcare said its new drug is effective in reducing seizures especially where conventional antiseizure medications have proven ineffective
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akumentis Healthcare said its new drug is effective in reducing seizures especially where conventional antiseizure medications have proven ineffective
The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies.
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement.
Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent
India Business News: Glenmark Pharmaceuticals has launched the first biosimilar of the popular anti-diabetic drug, Liraglutide in India. The drug, marketed as Lirafit, is